154 related articles for article (PubMed ID: 38785796)
1. Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation Analysis Reveal Insights into the Molecular Mechanism of
Li L; Mohammed AH; Auda NA; Alsallameh SMS; Albekairi NA; Muhseen ZT; Butch CJ
Biology (Basel); 2024 May; 13(5):. PubMed ID: 38785796
[TBL] [Abstract][Full Text] [Related]
2. Advanced network pharmacology study reveals multi-pathway and multi-gene regulatory molecular mechanism of Bacopa monnieri in liver cancer based on data mining, molecular modeling, and microarray data analysis.
Sadaqat M; Qasim M; Tahir Ul Qamar M; Masoud MS; Ashfaq UA; Noor F; Fatima K; Allemailem KS; Alrumaihi F; Almatroudi A
Comput Biol Med; 2023 Jul; 161():107059. PubMed ID: 37244150
[TBL] [Abstract][Full Text] [Related]
3. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
Elasbali AM; Al-Soud WA; Mousa Elayyan AE; Al-Oanzi ZH; Alhassan HH; Mohamed BM; Alanazi HH; Ashraf MS; Moiz S; Patel M; Patel M; Adnan M
J Biomol Struct Dyn; 2023; 41(23):14135-14151. PubMed ID: 36943780
[TBL] [Abstract][Full Text] [Related]
4. A network-based pharmacological investigation to identify the mechanistic regulatory pathway of andrographolide against colorectal cancer.
Janani B; Vijayakumar M; Priya K; Kim JH; Geddawy A; Shahid M; El-Bidawy MH; Al-Ghamdi S; Alsaidan M; Abdelzaher MH; Mohideen AP; Ramesh T
Front Pharmacol; 2022; 13():967262. PubMed ID: 36110531
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Danlou tablet on myocardial ischemia/ reperfusion injury assessed by network pharmacology and experimental verification.
Ye Y; Xiaoyang C; Junkai Y; Yueyao HU; Wei W
J Tradit Chin Med; 2024 Feb; 44(1):131-144. PubMed ID: 38213248
[TBL] [Abstract][Full Text] [Related]
6. Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer.
Li YJ; Tang DX; Yan HT; Yang B; Yang Z; Long FX
World J Clin Cases; 2023 Jul; 11(19):4553-4566. PubMed ID: 37469733
[TBL] [Abstract][Full Text] [Related]
7. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
[TBL] [Abstract][Full Text] [Related]
8. [Safety evaluation of Tibetan medicine Qishiwei Zhenzhu Pills based on serum pharmacochemistry and network pharmacology].
Yan ZY; Zong YH; Zhang CF; Wu LL; Qin LL; Liu TH
Zhongguo Zhong Yao Za Zhi; 2023 May; 48(9):2538-2551. PubMed ID: 37282883
[TBL] [Abstract][Full Text] [Related]
9. Exploring the pharmacological components and effective mechanism of Mori Folium against periodontitis using network pharmacology and molecular docking.
Wu Z; Ji X; Shan C; Song J; Zhao J
Arch Oral Biol; 2022 Jul; 139():105391. PubMed ID: 35430443
[TBL] [Abstract][Full Text] [Related]
10. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology integrated with molecular docking technology to reveal the potential mechanism of Shuganfang against drug-induced liver injury.
Wang Y; Chen X; Wang Y; Zhong H; Liu L; Ye Y
Medicine (Baltimore); 2023 Dec; 102(48):e36349. PubMed ID: 38050247
[TBL] [Abstract][Full Text] [Related]
12. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H
BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701
[TBL] [Abstract][Full Text] [Related]
13. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
[TBL] [Abstract][Full Text] [Related]
14. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
Han X; Liang L; He C; Ren Q; Su J; Cao L; Zheng J
BMC Complement Med Ther; 2023 Nov; 23(1):422. PubMed ID: 37990309
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the key prognostic genes and potential traditional Chinese medicine therapeutic targets in glioblastoma based on bioinformatics and network pharmacology methods.
Xia Z; Gao P; Chen Y; Shu L; Ye L; Cheng H; Dai X; Hu Y; Wang Z
Transl Cancer Res; 2022 May; 11(5):1386-1405. PubMed ID: 35706800
[TBL] [Abstract][Full Text] [Related]
16. Potential molecular mechanism of the Xiexin capsule in the intervention of dyslipidemia based on bioinformatics and molecular docking.
Yao K; Cai H; Wang Y; Cheng S; Liu Q; Zhang D; Chen Q; Chen X
Nutr Hosp; 2022 Jun; 39(3):569-579. PubMed ID: 35227068
[TBL] [Abstract][Full Text] [Related]
17. Exploring the mechanism of Xiaoqinglong decoction in the treatment of infantile asthma based on network pharmacology and molecular docking.
Chen D; Chen Q; Zhao K; Guo Y; Huang Y; Yuan Z; Cai Y; Li S; Xu J; Lin X
Medicine (Baltimore); 2023 Jan; 102(2):e32623. PubMed ID: 36637916
[TBL] [Abstract][Full Text] [Related]
18. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms predictive of Tibetan Medicine Sophora moorcroftiana alkaloids for treatment of lung cancer based on the network pharmacology and molecular docking.
Ji P; Zhao NS; Wu FL; Wei YM; Laba CD; Wujin CM; Hua YL; Yuan ZW; Yao WL
BMC Complement Med Ther; 2024 Jan; 24(1):47. PubMed ID: 38245694
[TBL] [Abstract][Full Text] [Related]
20. Active ingredients and molecular targets of
Zheng Y; Ji S; Li X; Feng Q
PeerJ; 2022; 10():e13737. PubMed ID: 35873910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
